Momenta Pharmaceuticals And Human Genome Sciences Have Come To An Understanding Regarding A Prior Contract Dispute; As Part Of The Dispute, Momenta Will Pay Human Genome Sciences $15M By Aug. 15, 2018 And $15M By July 1, 2019
Benzinga Newsdesk